Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Testosterone × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Dyspareunia 2 Arthralgia 2 Vaginitis 1 Sexual Dysfunction, Physiological 1 Osteoporosis 1 Neoplasms 1 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1

Interventions

Trastuzumab 27 Paclitaxel 26 Cyclophosphamide 26 Docetaxel 19 Taxes 17 Doxorubicin 17 Lapatinib 15 Radiotherapy 14 Capecitabine 12 Tamoxifen 11 Bevacizumab 11 Immunohistochemistry 9 Filgrastim 9 Carboplatin 9 Chemotherapy, Adjuvant 8 Biopsy 8 sargramostim 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 Gemcitabine 7 Albumin-Bound Paclitaxel 7 pegfilgrastim 6 exemestane 6 Vorinostat 6 Magnetic Resonance Spectroscopy 6 Letrozole 6 Immunoenzyme Techniques 6 Goserelin 6 Everolimus 6 Anastrozole 6 ixabepilone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05156606 2024-08-09

T&T

University Medical Center Groningen

Phase NA Terminated

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡